Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gigaxonin mutation analysis in patients with NIFID.

Neurobiology of aging - 1 Aug 2011

Dequen Florence, Cairns Nigel J, Bigio Eileen H, Julien Jean-Pierre

Abstract excerpt

Neuronal intermediate filament inclusion disease (NIFID) is a frontotemporal lobar degeneration (FTLD) characterized by frontotemporal dementia (FTD), pyramidal and extrapyramidal signs. The disease is histologically characterized by the presence of abnormal neuronal cytoplasmic inclusions (NCIs) which contain α-internexin and other neuronal intermediate filament (IF) proteins. Gigaxonin (GAN) is a cytoskeletal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytoskeletal Proteins
Share to Disease Models, Animal
Share to Frontotemporal Lobar Degeneration

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Intermediate Filaments

Share to Mice, Mutant Strains

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 19782434
DOI: 10.1016/j.neurobiolaging.2009.08.018
PMCID: PMC2987523

Genes

GAN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gigaxonin mutation analysis in patients with NIFID.PMID 19782434Read ↗

Identification of seven novel mutations in the GAN gene.Semantic proximity Read ↗

Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation.Semantic proximity Read ↗

Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.Semantic proximity Read ↗

Genotype-phenotype analysis in patients with giant axonal neuropathy (GAN).Semantic proximity Read ↗

Gigaxonin, mutated in Giant Axonal Neuropathy, interacts with TDP-43 and other RNA binding proteinsSemantic proximity Read ↗

The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy.Semantic proximity Read ↗

Two novel mutations in the GAN gene causing giant axonal neuropathy.Semantic proximity Read ↗

Clinical and molecular findings in patients with giant axonal neuropathy (GAN).Semantic proximity Read ↗

Alterations in lipid metabolism gene expression and abnormal lipid accumulation in fibroblast explants from giant axonal neuropathy patients.Semantic proximity Read ↗

Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID).Semantic proximity Read ↗

Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.Semantic proximity Read ↗

Proteomic analysis in giant axonal neuropathy: New insights into disease mechanismsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.